Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Preferential association of hepatitis C virus with CD19+ B cells is mediated by complement system.

Wang RY, Bare P, De Giorgi V, Matsuura K, Salam KA, Grandinetti T, Schechterly C, Alter HJ.

Hepatology. 2016 Dec;64(6):1900-1910. doi: 10.1002/hep.28842. Epub 2016 Oct 24.

2.

Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection.

Cacoub P, Bourlière M, Hausfater P, Charlotte F, Khiri H, Toci S, Piette JC, Poynard T, Halfon P.

J Viral Hepat. 2003 Jan;10(1):10-5.

PMID:
12558906
3.

CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.

D'Agosto G, Trento E, Nosotti L, Bordignon V, Battista M, Prignano G, Pimpinelli F, Biolcati G, Macrì A, Palamara G, Miglioresi L, Morrone A, Di Carlo A, Cordiali-Fei P, Ensoli F.

J Biol Regul Homeost Agents. 2009 Jul-Sep;23(3):155-64.

PMID:
19828092
4.

Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement.

Chen Z, Zhu Y, Ren Y, Tong Y, Hua X, Zhu F, Huang L, Liu Y, Luo Y, Lu W, Zhao P, Qi Z.

PLoS One. 2011 Apr 19;6(4):e18933. doi: 10.1371/journal.pone.0018933.

5.

Binding of Free and Immune Complex-Associated Hepatitis C Virus to Erythrocytes Is Mediated by the Complement System.

Salam KA, Wang RY, Grandinetti T, De Giorgi V, Alter HJ, Allison RD.

Hepatology. 2018 May 9. doi: 10.1002/hep.30087. [Epub ahead of print]

PMID:
29742812
6.
7.

Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.

Kozono Y, Abe R, Kozono H, Kelly RG, Azuma T, Holers VM.

J Immunol. 1998 Feb 15;160(4):1565-72.

8.

Detection of hepatitis C virus (HCV) negative strand RNA and NS3 protein in peripheral blood mononuclear cells (PBMC): CD3+, CD14+ and CD19+.

Pawełczyk A, Kubisa N, Jabłońska J, Bukowska-Ośko I, Caraballo Cortes K, Fic M, Laskus T, Radkowski M.

Virol J. 2013 Nov 26;10:346. doi: 10.1186/1743-422X-10-346.

9.

Hepatitis C virus (HCV) infection of peripheral blood mononuclear cells in patients with type II cryoglobulinemia.

Jabłońska J, Ząbek J, Pawełczyk A, Kubisa N, Fic M, Laskus T, Radkowski M.

Hum Immunol. 2013 Dec;74(12):1559-62. doi: 10.1016/j.humimm.2013.08.273. Epub 2013 Aug 28. Erratum in: Hum Immunol. 2017 Nov;78(11-12):768.

PMID:
23993984
10.

Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients.

Douam F, Bobay LM, Maurin G, Fresquet J, Calland N, Maisse C, Durand T, Cosset FL, Féray C, Lavillette D.

J Virol. 2015 Nov 4;90(2):992-1008. doi: 10.1128/JVI.02516-15. Print 2016 Jan 15.

11.

Enhanced RIG-I expression is mediated by interferon regulatory factor-2 in peripheral blood B cells from hepatitis C virus-infected patients.

Masumi A, Ito M, Mochida K, Hamaguchi I, Mizukami T, Momose H, Kuramitsu M, Tsuruhara M, Takizawa K, Kato A, Yamaguchi K.

Biochem Biophys Res Commun. 2010 Jan 22;391(4):1623-8. doi: 10.1016/j.bbrc.2009.12.092. Epub 2009 Dec 23.

PMID:
20034464
12.

Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.

Mongini PK, Jackson AE, Tolani S, Fattah RJ, Inman JK.

J Immunol. 2003 Nov 15;171(10):5244-54.

13.
14.

[The extrahepatic site of hepatitis C virus: clinical manifestations and prognostic value].

Krel' PE, Tsinzerling OD.

Ter Arkh. 2009;81(11):63-8. Review. Russian.

PMID:
20141018
15.

B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes.

Tucci FA, Broering R, Johansson P, Schlaak JF, Küppers R.

J Virol. 2013 Mar;87(5):2956-62. doi: 10.1128/JVI.03081-12. Epub 2012 Dec 26.

16.

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.

Marukian S, Jones CT, Andrus L, Evans MJ, Ritola KD, Charles ED, Rice CM, Dustin LB.

Hepatology. 2008 Dec;48(6):1843-50. doi: 10.1002/hep.22550.

17.

Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism.

Pal S, Sullivan DG, Kim S, Lai KK, Kae J, Cotler SJ, Carithers RL Jr, Wood BL, Perkins JD, Gretch DR.

Gastroenterology. 2006 Apr;130(4):1107-16.

PMID:
16618405
18.

Continuous release of hepatitis C virus (HCV) by peripheral blood mononuclear cells and B-lymphoblastoid cell-line cultures derived from HCV-infected patients.

Baré P, Massud I, Parodi C, Belmonte L, García G, Nebel MC, Corti M, Pinto MT, Bianco RP, Bracco MM, Campos R, Ares BR.

J Gen Virol. 2005 Jun;86(Pt 6):1717-27.

PMID:
15914850
19.

Investigation of residual hepatitis C virus in presumed recovered subjects.

Fujiwara K, Allison RD, Wang RY, Bare P, Matsuura K, Schechterly C, Murthy K, Marincola FM, Alter HJ.

Hepatology. 2013 Feb;57(2):483-91. doi: 10.1002/hep.25921. Epub 2012 Dec 6.

20.

Comparison of envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates.

Welker MW, Welsch C, Ochs D, Hofmann WP, Herrmann E, Piiper A, Hartmann RW, Zeuzem S, Sarrazin C, Kronenberger B.

J Viral Hepat. 2011 Mar;18(3):181-92. doi: 10.1111/j.1365-2893.2010.01296.x.

PMID:
20367804

Supplemental Content

Support Center